2013
DOI: 10.1007/s13277-013-0655-9
|View full text |Cite
|
Sign up to set email alerts
|

Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme

Abstract: Glioblastoma multiforme (GBM) is the most common and the most aggressive primary malignant tumor of the brain. Prognostic factors in GBM can be sorted as age, tumor localization, tumor diameter, symptom period and type, the extent of surgery, postoperative tumor volume, and adjuvant radiotherapy and/or chemotherapy status. Besides the interactions between actin microfilaments, microtubules, and intermediate filaments, environmental factors and intracellular signals which regulate them affect the cell invasion.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 34 publications
0
10
0
Order By: Relevance
“…Currently there is a lack of therapeutic agents targeting invasion and migration in GBM and there is a need for actionable targets involving these pathways. Having established that pCFL plays an integral role in GBM invasion, we explored how to target this pathway using small molecule inhibitors [ 12 , 13 , 26 ]. We tested LIMK1/2 and p-CFL inhibitors, BMS-5 and Cucurbitacin I.…”
Section: Resultsmentioning
confidence: 99%
“…Currently there is a lack of therapeutic agents targeting invasion and migration in GBM and there is a need for actionable targets involving these pathways. Having established that pCFL plays an integral role in GBM invasion, we explored how to target this pathway using small molecule inhibitors [ 12 , 13 , 26 ]. We tested LIMK1/2 and p-CFL inhibitors, BMS-5 and Cucurbitacin I.…”
Section: Resultsmentioning
confidence: 99%
“…The expression level of Cfl-2 has prognostic significance in primary leiomyosarcomas independent of the histopathological type of tumor, and its expression correlates with improved disease-specific survival [ 172 ]. Cfl-2 has also been identified in HMCs of non-muscle origin [ 173 , 174 , 175 , 176 ]. Cfl-2 has been overexpressed in aggressive breast cancer cell lines, and its expression has been correlated with tumor grade in primary breast cancer tissue [ 175 ].…”
Section: Members Of the Actin-depolymerizing Factor/cofilin Superfmentioning
confidence: 99%
“…In contrast, in pancreatic cancer, CFL2 showed lower expression compared with non-cancerous tissues [ 37 ]. The overexpression of CFL2 gene in glioblastoma multiforme contributes to increased therapeutic response [ 38 ]. These data suggested that the role of CFL2 varies in different kinds of cancers.…”
Section: Discussionmentioning
confidence: 99%